# Natto (Bacillus subtilis-fermented Glycine max)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/natto-bacillus-subtilis-fermented-glycine-max
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 1 / 10
**Category:** Fermented/Probiotic
**Also Known As:** Glycine max (fermented), Bacillus subtilis natto fermented soybeans, Itohiki-natto, Japanese fermented soybeans, NK (nattokinase)

## Overview

Natto delivers nattokinase (a 28 kDa fibrinolytic protease), menaquinone-7 (MK-7/vitamin K₂), γ-polyglutamic acid, and a metabolome of 569 unique compounds generated through Bacillus subtilis fermentation, collectively modulating coagulation, bone [metabolism](/ingredients/condition/weight-management), and [antioxidant](/ingredients/condition/antioxidant) defense pathways. A meta-analysis of clinical studies demonstrated that habitual natto intake elevates serum MK-7 levels (effect size d = 2.10, 95% CI [1.55, 2.66]) and produces a modestly significant increase in [bone mineral density](/ingredients/condition/bone-health) (d = 0.65, 95% CI [0.09, 1.21]).

## Health Benefits

- **Cardiovascular and Thrombotic Risk Reduction**: Nattokinase directly hydrolyzes fibrin clots and activates endogenous plasminogen, reducing thrombus burden; habitual consumption is associated with lower markers of hypercoagulability in observational data from Japanese cohorts.
- **[Bone Mineral Density](/ingredients/condition/bone-health) Support**: MK-7 at approximately 380 μg per 50-g serving carboxylates osteocalcin, directing calcium into bone matrix; meta-analysis confirms natto intake modestly increases BMD (d = 0.65) and reduces undercarboxylated osteocalcin (d = −0.50).
- **Isoflavone-Mediated [Antioxidant](/ingredients/condition/antioxidant) and Estrogenic Activity**: Fermentation amplifies genistein content to 16.4 times that of raw soybeans and glycine glycosides to 11.4 times, enabling enhanced estrogen receptor beta binding and free-radical scavenging relevant to post-menopausal bone and [cardiovascular health](/ingredients/condition/heart-health).
- **[Antimicrobial](/ingredients/condition/immune-support) and Anticancer Potential**: Natto polypeptides exhibit antibacterial effects in culture, while natto freeze-drying extract (NFDE) and natto water extract (NWE) induce [autophagy](/ingredients/condition/longevity) at low concentrations (<3 μg/mL) and shift to apoptosis at higher concentrations (5 μg/mL), suggesting concentration-dependent anticancer mechanisms.
- **Antiviral Defense**: Deoxyelephantopin, present at 105 times the concentration found in raw soybeans, demonstrates free-radical scavenging and direct antiviral activity against influenza A and herpes simplex virus in preclinical models.
- **[Gut Microbiome](/ingredients/condition/gut-health) Modulation**: Viable Bacillus subtilis spores in natto function as spore-forming probiotics that transiently colonize the gastrointestinal tract, modulating luminal pH and competitive exclusion of pathogens, with γ-polyglutamic acid acting as a prebiotic substrate.
- **Vitamin B12 Supplementation (Vegan Contexts)**: Natto is one of the few plant-derived foods containing biologically active cobalamin (vitamin B12) produced de novo by B. subtilis, offering a dietary source for populations avoiding animal products, though B12 content is variable and strain-dependent.

## Mechanism of Action

Nattokinase exerts fibrinolytic activity by directly cleaving fibrin at specific peptide bonds and by activating tissue plasminogen activator (tPA) and urokinase, effectively dissolving established thrombi; it is heat-stable up to 60°C and functional across a wide pH range (6–12), suggesting partial enzymatic survival through the upper gastrointestinal tract. Menaquinone-7 (MK-7) functions as an essential cofactor for γ-glutamyl carboxylase, the enzyme responsible for carboxylating vitamin K-dependent proteins including osteocalcin (bone), matrix Gla protein (vascular calcification prevention), and coagulation factors II, VII, IX, and X. Genistein and other amplified isoflavones bind estrogen receptor beta with moderate affinity, modulating gene expression involved in osteoblast differentiation, lipid [metabolism](/ingredients/condition/weight-management), and [inflammatory](/ingredients/condition/inflammation) cytokine production, while also inhibiting tyrosine kinase activity relevant to cell proliferation pathways. Deoxyelephantopin and the broader pool of 45 phenolic compounds and 70 flavonoids identified by metabolomic analysis collectively neutralize [reactive oxygen species](/ingredients/condition/antioxidant) through electron donation and metal chelation, protecting cellular membranes and DNA from oxidative damage.

## Clinical Summary

The most robust clinical dataset for natto comes from meta-analytic aggregation of studies examining MK-7-mediated bone outcomes, demonstrating a large effect on serum MK-7 elevation (d = 2.10, 95% CI [1.55, 2.66]), a small-to-moderate reduction in undercarboxylated osteocalcin (d = −0.50, 95% CI [−0.74, −0.26]), and a modest increase in [bone mineral density](/ingredients/condition/bone-health) (d = 0.65, 95% CI [0.09, 1.21]), with confidence intervals excluding zero across all primary endpoints. Nattokinase [cardiovascular](/ingredients/condition/heart-health) trials have demonstrated ex vivo and plasma fibrinolytic activity improvements, but these studies are generally small, lack standardized NK dosing across products, and have not yet reported hard cardiovascular event data in phase III trials. Anticancer investigations using NFDE and NWE represent early-phase cell line research showing concentration-dependent [autophagy](/ingredients/condition/longevity)-to-apoptosis transitions, which are mechanistically intriguing but not yet supported by human trial data. Overall clinical confidence is highest for vitamin K₂/bone endpoints, moderate for nattokinase fibrinolytic biomarkers, and preliminary for antiviral, [antimicrobial](/ingredients/condition/immune-support), and oncological applications.

## Nutritional Profile

Per 100 g of natto: approximately 18 g protein, 11 g fat (predominantly polyunsaturated), 12 g carbohydrate, and 5 g dietary fiber, with a caloric density of approximately 212 kcal. Micronutrient highlights include vitamin K₂ (MK-7) at approximately 760 μg/100 g—the highest known dietary concentration globally—along with meaningful amounts of iron (~3.6 mg), manganese (~1.5 mg), copper, magnesium (~115 mg), and phosphorus (~190 mg). The fermentation process substantially elevates bioavailability of isoflavones (genistein 16.4-fold vs. raw soybeans), generates de novo vitamin B12, and converts bound phytate-complexed minerals into more absorbable free ionic forms. The amino acid profile per 100 g includes glutamate (3.4 g), leucine (1.6 g), and proline (1.5 g), along with 14 total quantified amino acids; γ-polyglutamic acid (γ-PGA) is a unique fermentation-derived polymer contributing to the characteristic viscous texture and potentially enhancing mineral absorption in the gut.

## Dosage & Preparation

- **Traditional Whole Food (Japan)**: Standard serving is 40–100 g of fermented soybeans per day, providing approximately 304–760 μg MK-7 and meaningful nattokinase activity; consumed typically at breakfast over rice.
- **Nattokinase Capsules/Tablets**: Standardized to fibrinolytic units (FU); commonly marketed at 1,000–4,000 FU per capsule (equivalent to approximately 100–400 mg nattokinase extract); clinical protocols have used 2,000 FU twice daily, best taken on an empty stomach to maximize gastric survival.
- **MK-7 Isolated Supplements (Natto-Derived)**: Purified MK-7 at 90–360 μg/day mirrors the dose found in standard natto servings; 180–360 μg/day used in [bone health](/ingredients/condition/bone-health) trials; take with a fat-containing meal for optimal absorption as MK-7 is fat-soluble.
- **Natto Freeze-Dried Extract (NFDE) / Powder**: Used in research formulations; concentrates nattokinase, isoflavones, and γ-PGA; no universally standardized commercial dose established.
- **[Probiotic](/ingredients/condition/gut-health)/Spore Supplement (B. subtilis natto)**: Available as spore preparations at 1–10 billion CFU per serving; distinct from nattokinase supplements and intended for gut modulation rather than fibrinolytic effects.
- **Timing Note**: Nattokinase supplements are generally recommended away from anticoagulant medication administration windows and should be discontinued at least one week before elective surgery due to fibrinolytic activity.

## Safety & Drug Interactions

Natto and nattokinase supplements are generally well tolerated at typical dietary serving sizes, with the primary safety concern being enhanced anticoagulant and antiplatelet activity; concurrent use with warfarin (Coumadin) creates a dual interaction—nattokinase amplifies fibrinolysis while the high MK-7 content (a vitamin K₂ source) can competitively antagonize warfarin's vitamin K epoxide reductase inhibition, making INR unpredictable and potentially dangerous. Individuals receiving anticoagulants (warfarin, rivaroxaban, apixaban, dabigatran), antiplatelet agents (aspirin, clopidogrel), or thrombolytic therapies should avoid therapeutic nattokinase supplementation except under direct medical supervision with coagulation monitoring. Soy allergy represents an absolute contraindication; individuals with [thyroid](/ingredients/condition/hormonal) dysfunction should be aware that soy isoflavones at high intake levels may modestly inhibit thyroid peroxidase, and timing of natto consumption relative to thyroid hormone medication should be spaced by at least four hours. Pregnancy and lactation safety data for supplemental-dose nattokinase or concentrated MK-7 extracts are insufficient to establish safety beyond normal dietary natto intake; pregnant individuals on vitamin K-restricted protocols (rare) should consult their obstetrician before regular natto consumption.

## Scientific Research

The strongest and most quantified clinical evidence for natto centers on its MK-7 content and bone health outcomes: a published meta-analysis of multiple controlled studies found that habitual natto intake significantly elevated serum MK-7 (d = 2.10), increased carboxylated osteocalcin (d = 0.26), decreased undercarboxylated osteocalcin (d = −0.50), and produced modest but statistically significant gains in [bone mineral density](/ingredients/condition/bone-health) (d = 0.65), establishing moderate-to-strong evidence in this domain. Nattokinase has been evaluated in small human trials and in vitro fibrinolytic assays demonstrating enzymatic clot dissolution activity, but large-scale randomized controlled trials with clinical [cardiovascular](/ingredients/condition/heart-health) endpoints remain limited, placing cardiovascular evidence at a preliminary-to-moderate tier. Metabolomic studies have comprehensively catalogued 569 bioactive metabolites in natto—including 70 flavonoids, 60 amino acids, 76 alkaloids, 45 phenolics, and 27 nucleotides—providing a rigorous biochemical foundation, but most [antimicrobial](/ingredients/condition/immune-support), antiviral, and anticancer findings rely on in vitro cell culture models without human translation data. The vitamin B12 content of natto has been confirmed analytically, but clinical trials specifically quantifying its efficacy as a B12 source in deficient populations are sparse, requiring cautious interpretation.

## Historical & Cultural Context

Natto's origins in Japan are traditionally traced to the early Heian period (approximately 10th–11th century CE), with one popular legend attributing its discovery to Yoshiie Minamoto, whose troops accidentally fermented soybeans wrapped in straw during a military campaign. For centuries, natto was prepared by wrapping steamed soybeans in rice straw naturally colonized by Bacillus subtilis, allowing spontaneous fermentation at ambient temperature; industrial production replaced straw with controlled B. subtilis starter cultures in the 20th century. In Japanese folk medicine, natto has long been credited with promoting [longevity](/ingredients/condition/longevity), circulatory health, and digestive robustness, overlapping with the modern scientific discovery of nattokinase by Dr. Hiroyuki Sumi at Chicago University in 1980. Regional preferences within Japan vary significantly—Kanto consumers favor the softer Okame-style natto, while Kansai populations have historically shown lower consumption rates—creating natural epidemiological gradients that have informed epidemiological research on natto's health effects.

## Synergistic Combinations

Natto's MK-7 works synergistically with vitamin D3, which upregulates osteocalcin gene transcription and increases the substrate available for K₂-dependent carboxylation, making a combined MK-7 (180–360 μg) plus D3 (1,000–2,000 IU) stack a well-supported strategy for [bone mineral density](/ingredients/condition/bone-health) optimization supported by multiple intervention studies. Nattokinase fibrinolytic activity may complement omega-3 fatty acids (EPA/DHA), which reduce platelet aggregation and [inflammatory](/ingredients/condition/inflammation) thrombus formation through COX and lipoxygenase pathway modulation, providing complementary antithrombotic mechanisms at the enzymatic and lipid mediator levels respectively; however, this combination amplifies bleeding risk and requires clinical caution. Natto's [prebiotic](/ingredients/condition/gut-health) γ-PGA component may enhance the efficacy of co-administered probiotic formulations by providing a fermentable substrate that sustains probiotic colony viability in the colon, making natto a logical whole-food adjunct to multi-strain probiotic protocols.

## Frequently Asked Questions

### How much vitamin K2 is in natto per serving?

A standard 50-gram serving of natto provides approximately 380 μg of menaquinone-7 (MK-7), making it the single richest dietary source of vitamin K₂ in the world. This far exceeds the adequate intake levels established for vitamin K and is sufficient to significantly elevate serum MK-7 concentrations, as confirmed by meta-analysis (effect size d = 2.10).

### Can nattokinase replace blood thinners like warfarin?

Nattokinase should never be used as a direct replacement for prescribed anticoagulants such as warfarin without physician supervision, as its fibrinolytic mechanism differs from vitamin K antagonism and its potency is not standardized across products. Critically, natto's high MK-7 content can counteract warfarin's mechanism, making INR levels unpredictable; anyone on anticoagulant therapy must consult their physician before consuming nattokinase supplements or regular natto servings.

### Is natto a reliable source of vitamin B12 for vegans?

Natto contains biologically active vitamin B12 produced de novo by Bacillus subtilis during fermentation, and it is one of the very few plant-derived foods with confirmed cobalamin content. However, B12 levels vary significantly by strain and batch, and no large-scale clinical trial has established natto as a sufficient sole source of B12 for deficient vegans; it may contribute meaningfully but should be combined with other verified B12 sources or supplements.

### What is the best way to take nattokinase supplements for cardiovascular health?

Clinical research protocols and manufacturer recommendations typically suggest nattokinase at 1,000–2,000 fibrinolytic units (FU) taken one to two times daily on an empty stomach, as stomach acid and food may partially reduce enzymatic activity before intestinal absorption. Nattokinase is heat-stable up to 60°C, so cold natto retains more activity than cooked preparations; supplementation should be timed away from anticoagulant medications and discontinued at least one week before any elective surgical procedure.

### Does eating natto daily actually improve bone density?

Meta-analytic evidence from multiple controlled studies indicates that habitual natto intake produces a modestly significant increase in bone mineral density (effect size d = 0.65, 95% CI [0.09, 1.21]), accompanied by increases in carboxylated osteocalcin (d = 0.26) and reductions in undercarboxylated osteocalcin (d = −0.50), both favorable bone metabolism markers. These effects are attributed primarily to natto's exceptionally high MK-7 content, which carboxylates osteocalcin to direct calcium into bone matrix, with the most pronounced effects observed in postmenopausal women who are at greatest risk of bone loss.

### Does natto interact with anticoagulant or antiplatelet medications?

Natto contains nattokinase and high levels of vitamin K2, both of which can potentiate anticoagulant effects; concurrent use with warfarin, apixaban, dabigatran, or aspirin may increase bleeding risk and requires medical supervision. Patients taking these medications should consult their healthcare provider before consuming natto or nattokinase supplements regularly. The vitamin K2 content can also reduce warfarin efficacy if intake is inconsistent, creating additional monitoring challenges.

### What is the difference between eating whole natto versus taking nattokinase supplements?

Whole natto provides nattokinase alongside vitamin K2 (MK-7), probiotics, and additional nutrients from fermented soybeans, while isolated nattokinase supplements deliver only the fibrinolytic enzyme without vitamin K2. Whole natto offers approximately 100 mg of nattokinase activity per serving, whereas supplemental nattokinase often contains 2,000 FU (fibrinolytic units) or higher in concentrated form. The choice depends on whether vitamin K2 intake and food-based fermentation benefits are priorities for your health goals.

### Who should avoid natto or nattokinase supplementation?

Individuals with active bleeding disorders, those scheduled for surgery within 2 weeks, and patients on anticoagulants should avoid natto and nattokinase without medical clearance due to increased hemorrhage risk. People with soy allergies or severe legume sensitivities must avoid natto entirely, as it is fermented soy. Individuals with vitamin K-dependent conditions or those requiring consistent warfarin dosing should also exercise caution due to natto's high MK-7 content.

### What does nattokinase do in the body?

Nattokinase is a 28 kDa serine protease that directly cleaves fibrin strands within blood clots and simultaneously upregulates endogenous fibrinolytic agents tissue plasminogen activator (tPA) and urokinase, promoting thrombus dissolution. It also degrades plasminogen activator inhibitor-1 (PAI-1), further tilting the hemostatic balance toward fibrinolysis. Clinical studies have documented measurable improvements in plasma fibrinolytic activity and reductions in fibrinogen levels, though large-scale cardiovascular event trials are still ongoing.

### How does natto differ from taking a nattokinase or vitamin K2 supplement?

Whole natto delivers a matrix of 569 metabolomically identified compounds—including γ-polyglutamic acid, isoflavones, phenolics, and flavonoids—that a single-ingredient supplement cannot replicate. The food matrix may also support enzyme stability and modulate gut absorption kinetics differently than encapsulated extract. However, standardized supplements allow precise dosing of nattokinase fibrinolytic units (FU) or MK-7 micrograms, which is difficult to achieve with variable batches of fermented soybean.

### Is natto safe for people taking blood thinners or warfarin?

Natto poses a clinically significant interaction risk for patients on warfarin because its high MK-7 content (a long half-life vitamin K₂) can directly compete with warfarin's mechanism of inhibiting γ-glutamyl carboxylase-dependent clotting factor activation, reducing anticoagulant efficacy. Nattokinase's additive fibrinolytic activity may compound bleeding risk if combined with antiplatelet agents or direct oral anticoagulants (DOACs). Patients on any anticoagulant or antiplatelet therapy should consult a clinician before consuming natto or nattokinase supplements.

### What is the evidence that natto supports bone health?

A meta-analysis of clinical studies found that habitual natto intake produced a large elevation in serum MK-7 (effect size d = 2.10, 95% CI [1.55, 2.66]), a significant reduction in undercarboxylated osteocalcin—a marker of poor bone matrix quality—(d = −0.50, 95% CI [−0.74, −0.26]), and a modest but statistically significant increase in bone mineral density (d = 0.65, 95% CI [0.09, 1.21]). The mechanism centers on MK-7 acting as a cofactor for γ-glutamyl carboxylase, enabling carboxylation and activation of osteocalcin and matrix Gla protein, which regulate hydroxyapatite deposition and vascular calcification respectively. All three primary endpoints had confidence intervals excluding zero, making bone health the highest-confidence clinical application for natto.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*